WallStSmart

Kenvue Inc. (KVUE)vsRaytech Holding Limited Ordinary Shares (RAY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 10703% more annual revenue ($15.41B vs $142.63M). RAY leads profitability with a 11.7% profit margin vs 10.8%. RAY trades at a lower P/E of 3.1x. RAY earns a higher WallStSmart Score of 63/100 (C+).

KVUE

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 7.0Value: 4.0Quality: 5.0
Piotroski: 4/9Altman Z: 1.22

RAY

Buy

63

out of 100

Grade: C+

Growth: 10.0Profit: 6.0Value: 6.7Quality: 7.5
Piotroski: 3/9Altman Z: 2.74
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KVUESignificantly Overvalued (-86.1%)

Margin of Safety

-86.1%

Fair Value

$9.96

Current Price

$18.98

$9.02 premium

UndervaluedFair: $9.96Overvalued

Intrinsic value data unavailable for RAY.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KVUE0 strengths · Avg: 0/10

No standout strengths identified

RAY5 strengths · Avg: 9.4/10
P/E RatioValuation
3.1x10/10

Attractively priced relative to earnings

Price/BookValuation
0.5x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
196.0%10/10

Revenue surging 196.0% year-over-year

Debt/EquityHealth
0.119/10

Conservative balance sheet, low leverage

EPS GrowthGrowth
33.5%8/10

Earnings expanding 33.5% YoY

Areas to Watch

KVUE3 concerns · Avg: 3.3/10
PEG RatioValuation
1.594/10

Expensive relative to growth rate

Revenue GrowthGrowth
3.0%4/10

3.0% revenue growth

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

RAY3 concerns · Avg: 2.7/10
Market CapQuality
$16.68M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Free Cash FlowQuality
$-16.14M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : KVUE

KVUE has a balanced fundamental profile.

Bull Case : RAY

The strongest argument for RAY centers on P/E Ratio, Price/Book, Revenue Growth. Revenue growth of 196.0% demonstrates continued momentum.

Bear Case : KVUE

The primary concerns for KVUE are PEG Ratio, Revenue Growth, Altman Z-Score.

Bear Case : RAY

The primary concerns for RAY are Market Cap, Piotroski F-Score, Free Cash Flow.

Key Dynamics to Monitor

KVUE profiles as a value stock while RAY is a growth play — different risk/reward profiles.

KVUE carries more volatility with a beta of 0.43 — expect wider price swings.

RAY is growing revenue faster at 196.0% — sustainability is the question.

KVUE generates stronger free cash flow (549M), providing more financial flexibility.

Bottom Line

RAY scores higher overall (63/100 vs 58/100) and 196.0% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Raytech Holding Limited Ordinary Shares

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Raytech Holding Limited is an innovative technology firm dedicated to revolutionizing the telecommunications, energy, and smart technology sectors through advanced research and strategic partnerships. With a strong commitment to developing sustainable, cutting-edge solutions, the company enhances operational efficiency and fosters long-term shareholder growth. As it expands its global footprint, Raytech strives to meet the dynamic demands of modern infrastructure, positioning itself as a key player in the evolving technology landscape.

Want to dig deeper into these stocks?